{
"info": {
"nct_id": "NCT00697476",
"official_title": "Phase I-II Study of Oral Suberoylanilide Hydroxamic Acid (Vorinostat) in Combination With Topotecan in Patients With Chemosensitive Recurrent Small Cell Lung Cancer (SCLC)",
"inclusion_criteria": "* Histologically or cytologically proven diagnosis of SCLC;\n* Limited or extensive-stage disease in patients who have received a single chemotherapy regimen or combined modality (chemotherapy + chest radiotherapy) regimen and relapsed after completion of first-line chemotherapy (sensitive relapse);\n* Age >/= 18 years;\n* ECOG Performance Status 0-2;\n* Life expectancy of at least 12 weeks;\n* Measurable lesions according to RECIST criteria;\n* Adequate cardiac, hepatic, renal, and bone marrow function;\n* Written informed consent.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Prior treatment with an HDAC inhibitor;\n* Symptomatic and/or unstable pre-existing brain metastases;\n* Superior Vena Cava Syndrome;\n* Spinal cord compression;\n* Severe or uncontrolled medical diseases (Hypertension, diabetes, congestive heart failure, myocardial infarction within 6 months of study, chronic renal disease, or active uncontrolled infections);\n* Other co-existing malignancies or malignancies diagnosed within the last 5 years with the exception of basal cell carcinoma or cervical cancer in situ;\n* Pregnant or breastfeeding women.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically or cytologically proven diagnosis of SCLC;",
"criterions": [
{
"exact_snippets": "Histologically or cytologically proven diagnosis of SCLC",
"criterion": "SCLC diagnosis",
"requirements": [
{
"requirement_type": "method of diagnosis",
"expected_value": [
"histologically",
"cytologically"
]
}
]
}
]
},
{
"line": "* Limited or extensive-stage disease in patients who have received a single chemotherapy regimen or combined modality (chemotherapy + chest radiotherapy) regimen and relapsed after completion of first-line chemotherapy (sensitive relapse);",
"criterions": [
{
"exact_snippets": "Limited or extensive-stage disease",
"criterion": "disease stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"limited",
"extensive"
]
}
]
},
{
"exact_snippets": "patients who have received a single chemotherapy regimen",
"criterion": "chemotherapy regimen count",
"requirements": [
{
"requirement_type": "count",
"expected_value": {
"operator": "=",
"value": 1,
"unit": "regimen"
}
}
]
},
{
"exact_snippets": "combined modality (chemotherapy + chest radiotherapy) regimen",
"criterion": "treatment modality",
"requirements": [
{
"requirement_type": "modality",
"expected_value": "combined (chemotherapy + chest radiotherapy)"
}
]
},
{
"exact_snippets": "relapsed after completion of first-line chemotherapy (sensitive relapse)",
"criterion": "relapse type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "sensitive relapse"
}
]
}
]
},
{
"line": "* Age >/= 18 years;",
"criterions": [
{
"exact_snippets": "Age >/= 18 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* ECOG Performance Status 0-2;",
"criterions": [
{
"exact_snippets": "ECOG Performance Status 0-2",
"criterion": "ECOG Performance Status",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Life expectancy of at least 12 weeks;",
"criterions": [
{
"exact_snippets": "Life expectancy of at least 12 weeks",
"criterion": "life expectancy",
"requirements": [
{
"requirement_type": "duration",
"expected_value": {
"operator": ">=",
"value": 12,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Measurable lesions according to RECIST criteria;",
"criterions": [
{
"exact_snippets": "Measurable lesions according to RECIST criteria",
"criterion": "lesions",
"requirements": [
{
"requirement_type": "measurability",
"expected_value": "RECIST criteria"
}
]
}
]
},
{
"line": "* Adequate cardiac, hepatic, renal, and bone marrow function;",
"criterions": [
{
"exact_snippets": "Adequate cardiac ... function",
"criterion": "cardiac function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "Adequate ... hepatic ... function",
"criterion": "hepatic function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "Adequate ... renal ... function",
"criterion": "renal function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
},
{
"exact_snippets": "Adequate ... bone marrow function",
"criterion": "bone marrow function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* Written informed consent.",
"criterions": [
{
"exact_snippets": "Written informed consent.",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Prior treatment with an HDAC inhibitor;",
"criterions": [
{
"exact_snippets": "Prior treatment with an HDAC inhibitor",
"criterion": "HDAC inhibitor treatment",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": true
}
]
}
]
},
{
"line": "* Symptomatic and/or unstable pre-existing brain metastases;",
"criterions": [
{
"exact_snippets": "Symptomatic and/or unstable pre-existing brain metastases",
"criterion": "brain metastases",
"requirements": [
{
"requirement_type": "symptomatic",
"expected_value": true
},
{
"requirement_type": "stability",
"expected_value": "unstable"
}
]
}
]
},
{
"line": "* Superior Vena Cava Syndrome;",
"criterions": [
{
"exact_snippets": "Superior Vena Cava Syndrome",
"criterion": "Superior Vena Cava Syndrome",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Spinal cord compression;",
"criterions": [
{
"exact_snippets": "Spinal cord compression",
"criterion": "spinal cord compression",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Severe or uncontrolled medical diseases (Hypertension, diabetes, congestive heart failure, myocardial infarction within 6 months of study, chronic renal disease, or active uncontrolled infections);",
"criterions": [
{
"exact_snippets": "Severe or uncontrolled medical diseases (Hypertension",
"criterion": "hypertension",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "Severe or uncontrolled medical diseases ... diabetes",
"criterion": "diabetes",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "Severe or uncontrolled medical diseases ... congestive heart failure",
"criterion": "congestive heart failure",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "Severe or uncontrolled medical diseases ... myocardial infarction within 6 months of study",
"criterion": "myocardial infarction",
"requirements": [
{
"requirement_type": "time since event",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
},
{
"exact_snippets": "Severe or uncontrolled medical diseases ... chronic renal disease",
"criterion": "chronic renal disease",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "control",
"expected_value": false
}
]
},
{
"exact_snippets": "Severe or uncontrolled medical diseases ... active uncontrolled infections",
"criterion": "active uncontrolled infections",
"requirements": [
{
"requirement_type": "control",
"expected_value": false
}
]
}
]
},
{
"line": "* Other co-existing malignancies or malignancies diagnosed within the last 5 years with the exception of basal cell carcinoma or cervical cancer in situ;",
"criterions": [
{
"exact_snippets": "Other co-existing malignancies",
"criterion": "co-existing malignancies",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "malignancies diagnosed within the last 5 years",
"criterion": "malignancies diagnosed within the last 5 years",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "exception of basal cell carcinoma or cervical cancer in situ",
"criterion": "basal cell carcinoma or cervical cancer in situ",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Pregnant or breastfeeding women.",
"criterions": [
{
"exact_snippets": "Pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "breastfeeding women",
"criterion": "breastfeeding",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}